GlobeNewswire by notified

Iveco Group announces the results of the Annual General Meeting

Share

Turin, 17th April 2024. Iveco Group N.V. (EXM: IVG) (the Company or IVG) announces that its shareholders approved all the resolutions proposed by the Board of Directors (the Board) at its Annual General Meeting (AGM) held today in Amsterdam, the Netherlands.

The AGM:

  • adopted the 2023 Annual Financial Statements;
  • approved the proposal to distribute a cash dividend of euro 0.22 per outstanding common share. IVG common shares will be quoted ex-dividend on 22nd April 2024. The record date for the dividend will be 23rd April 2024 and the dividend will be paid on 24th April 2024;
  • expressed a majority of votes in favour of the Remuneration Report for the Financial Year 2023;
  • granted Executive and Non-Executive Directors discharge from liability for the exercise of their duties in the Financial Year 2023;
  • reappointed Suzanne Heywood and Gerrit Marx as Executive Directors, (re)appointed Judy Curran, Tufan Erginbilgic, Essimari Kairisto, Linda Knoll, Alessandro Nasi, Olof Persson and Lorenzo Simonelli as Non-Executive Directors of the Company. Subsequently, the Board confirmed Ms Heywood, Mr Marx and Mr Simonelli as Chairperson, Chief Executive Officer and Senior Non-Executive Director, respectively;
  • re-appointed Deloitte Accountants B.V. as the Company’s Independent Auditor;
  • authorised the Board to repurchase up to 10,000,000 Common Shares with a maximum total allocation of €130,000,000 for a period of 18 months from the date of the AGM. The new authorisation replaces the pre-existing one granted by the Annual General Meeting of Shareholders on 14th April 2023.

In addition, the AGM discussed the Company’s dividend policy, the chapter in the Annual Report outlining the Company’s corporate governance structure and compliance with the Dutch Corporate Governance Code as revised in 2022, and the Company’s voluntary Sustainability Report.

Details of all matters discussed today at the AGM are available on the Company’s website (www.ivecogroup.com), where the Chairperson’s and the Chief Executive Officer’s presentations, as well as the voting results, will be posted shortly.

Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society. The eight brands are each a major force in its specific business: IVECO, a pioneering commercial vehicles brand that designs, manufactures, and markets heavy, medium, and light-duty trucks; FPT Industrial, a global leader in a vast array of advanced powertrain technologies in the agriculture, construction, marine, power generation, and commercial vehicles sectors; IVECO BUS and HEULIEZ, mass-transit and premium bus and coach brands; IDV, for highly specialised defence and civil protection equipment; ASTRA, a leader in large-scale heavy-duty quarry and construction vehicles; MAGIRUS, the industry-reputed firefighting vehicle and equipment manufacturer; and IVECO CAPITAL, the financing arm which supports them all. Iveco Group employs more than 36,000 people around the world and has 20 industrial sites and 29 R&D centres. Further information is available on the Company’s website www.ivecogroup.com

Media Contacts:
Francesco Polsinelli, Tel: +39 335 1776091
Fabio Lepore, Tel: +39 335 7469007
E-mail: mediarelations@ivecogroup.com

Investor Relations:
Federico Donati, Tel: +39 011 0073539
E-mail: investor.relations@ivecogroup.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Lerøy Seafood Group ASA: Annual report for 202330.4.2024 06:30:00 CEST | Press release

Please find attached Lerøy Seafood Group ASA's annual report for 2023. The annual report is also attached in a machine-readable format according to ESEF (European Single Electronic Format). As part of the group’s integrated reporting, an overview of priorities, measurements, and targets within environment, social and governance (“ESG”) is included. The Board of Directors has proposed a dividend payment of NOK 2.50 per share for distribution in 2024. Key dates are set out in a separate stock exchange announcement. This information is subject to the disclosure requirements according to Section 5-12 of the Norwegian Securities Trading Act. Attachments LSG annual report 20235967007LIEEXZXJ2JK50-2023-12-31-en

Lerøy Seafood Group ASA: Årsrapport for 202330.4.2024 06:30:00 CEST | Pressemelding

Vedlagt følger årsrapport for Lerøy Seafood Group ASA for 2023. Som del av konsernets integrerte rapportering inneholder årsrapporten en oversikt over fokusområder, måleindikatorer og mål innen miljø, samfunnsmessig og finansiell bærekraft (ESG). Årsrapporten er også vedlagt i et maskinlesbart format i tråd med ESEF (European Single Electronic Format). Styret har foreslått et utbytte til utbetaling i 2024 på NOK 2,50 per aksje. Det vises til egen børsmelding med relevante datoer. Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12. Vedlegg LSG annual report 20235967007LIEEXZXJ2JK50-2023-12-31-en

TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer30.4.2024 00:40:00 CEST | Press release

Company Announcement Full approval based on global Phase 3 study demonstrating overall survival benefit of TIVDAK compared to chemotherapyTIVDAK is the first antibody-drug conjugate in this patient population to have positive overall survival data COPENHAGEN, Denmark; April 30, 2024 – Genmab A/S (Nasdaq: GMAB) and Pfizer Inc. (NYSE: PFE) announced today the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. This FDA action converts the September 2021 accelerated approval of TIVDAK to a full approval. TIVDAK is the first antibody-drug conjugate (ADC) with demonstrated overall survival data to be granted full FDA approval in this patient population. The approval is based on results from the global, randomized, Phase 3 innovaTV 301 clinical trial (NCT04697628), in which TIV

GOGL – 2024 AGM Results Notification29.4.2024 23:22:57 CEST | Press release

Golden Ocean Group Limited (the “Company”) advises that the 2024 Annual General Meeting of the Shareholders of the Company was held on April 29, 2024, at 16:30 hrs, at Hamilton Princess and Beach Club, 76 Pitts Bay Road, Hamilton HMCX, Bermuda. The audited consolidated financial statements for the Company for the year ended December 31, 2023 were presented to the Meeting. In addition, the following resolutions were passed: To set the maximum number of Directors to be not more than eight. To resolve that vacancies in the number of Directors be designated as casual vacancies and that the Board of Directors be authorized to fill such vacancies as and when it deems fit. To re-elect Ola Lorentzon as a Director of the Company. To re-elect John Fredriksen as a Director of the Company To re-elect James O’Shaughnessy as a Director of the Company. To re-elect Ben Mills as a Director of the Company. To re-elect Cato Stonex as a Director of the Company. To re-appoint PricewaterhouseCoopers AS as a

SFL - 2024 AGM Results Notification29.4.2024 22:16:00 CEST | Press release

SFL Corporation Ltd. (NYSE: SFL) (“SFL” or the “Company”) advises that the 2024 Annual General Meeting of the Company was held on April 29, 2024, at 9:45 hours at Hamilton Princess and Beach Club, 76 Pitts Bay Road, Hamilton HMCX, Bermuda. The audited consolidated financial statements for the Company for the year ended December 31, 2023, were presented to the Meeting. In addition, the following resolutions were passed: 1. To set the maximum number of Directors to be not more than eight. 2. To resolve that vacancies in the number of Directors be designated as casual vacancies and that the Board of Directors be authorised to fill such vacancies as and when it deems fit. 3. To re-elect Kathrine Fredriksen as a Director of the Company. 4. To re-elect Gary Vogel as a Director of the Company. 5. To re-elect Keesjan Cordia as a Director of the Company. 6. To re-elect James O’Shaughnessy as a Director of the Company. 7. To re-elect Ole Hjertaker as a Director of the Company. 8. To re-elect Wil

HiddenA line styled icon from Orion Icon Library.Eye